1[1]Kannel WB. Epidemiology and prevention of cardiac failure:Framinhham study insights. Eur Heart J, 1987, 8(Suppl F):23～26
2[2]Haldeman GA, Croft JB, Giles WH, et al. Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985～1995. Am Heart J, 1999, 137(2): 352～360
3[3]Cleland JG, Clark A. Has the survival of the heat failure population changed? Lessons from trials. Am J Cardiol, 1999, 83 (SB): 112D～ 119D
4[6]Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J, 1997, 133(6): 703～712
5[7]Gheorghiade M, Bonow RO. Chronic heart failure in the United States: a manifestation of coronary artery disease.Circulation, 1998, 97:282～289
6[9]Shindler DM, Kostis JB, Yusuf S, et al. Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trial and Registry. Am J Cardiol, 1996, 77(11): 1017～1020
7[10]Zieman SJ, Fortuin NJ. Hypertrophic and restrictive cardiomyopathies in the elderly. Cardiol Clin, 1999, 17 (1):159～172, ix
8[11]Heerdink ER, Leufkens HG, Herings RM, et al. NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Arch Intern Med, 1998,158(10): 1108～1112
5Mckee PA,Castell WP,McNamara PM,et al.The natural history of congestive heart failure,the framingham study [J].N Engl J Med,1971,285(26):1441-1446.
6The Criteria Committee of New York Heart Association.1994 revisions to classification of functional capacity and objective assessment of patients with diseases of the heart [J].Circulation,1994,90(1):644-645.
